Literature DB >> 2974748

Physiological implications of the alteration of 6-phosphofructo-1-kinase isozyme pools during brain development and aging.

G A Dunaway1, T P Kasten.   

Abstract

The 6-phosphofructo-1-kinase (PFK) isozyme pools from brains of fetal, neonatal, young adult (3 months) and aged (30 months) rats were studied using chromatographic and immunological techniques. Also, the changing subunit composition of each isozyme pool was determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis on 6% slab gels and by immunoblotting with subunit-specific antibodies. The total PFK activity increased over seven-fold during the 30 days following birth, and the L-type, M-type, and C-type subunits increased approximately 2-fold, 7-fold, and 24-fold, respectively. In the near-term fetal brain and early neonatal brain, the L-type and M-type subunits were the predominant forms and were present in approximately equal amounts. During the second second week of postnatal brain maturation, the levels of the M-type and C-type subunit began to significantly increase. Consequently, during postnatal development, the isozyme pools switched from L-M-rich forms to M-C-rich forms. In aged brain relative to the young adult (3 months) brain, the 20% loss of total activity was associated with 27% and 18% losses of the M-type and C-type subunits, respectively. Examination of the regulatory properties of the various PFK isozyme pools revealed that at the low concentration of fructose-6-P and high level of ATP which are thought to occur in vivo, fructose-2,6-P2 was required for measurable PFK activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974748     DOI: 10.1016/0006-8993(88)90233-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Alteration of the levels of the M-type 6-phosphofructo-1-kinase mRNA isoforms during neonatal maturation of heart, brain and muscle.

Authors:  Y Mhaskar; G Armour; G Dunaway
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

2.  Age-related changes in subunit composition and regulation of hepatic 6-phosphofructo-1-kinase.

Authors:  G A Dunaway; T P Kasten; S Crabtree; Y Mhaskar
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

3.  Resistance of brain phosphofructo-1-kinase to pH-dependent inhibition.

Authors:  S E Bazaes; R G Kemp
Journal:  Metab Brain Dis       Date:  1990-09       Impact factor: 3.584

4.  Hexose diphosphates and phosphofructokinase in rat brain during development.

Authors:  G J Dombrowski; K R Swiatek; K L Chao
Journal:  Neurochem Res       Date:  1994-10       Impact factor: 3.996

5.  Anaerobic function of CNS white matter declines with age.

Authors:  Margaret A Hamner; Thomas Möller; Bruce R Ransom
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-22       Impact factor: 6.200

6.  Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21.

Authors:  A Elson; D Levanon; Y Weiss; Y Groner
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

7.  Regulation of brain 6-phosphofructo-1-kinase: effects of aging, fructose-2,6-bisphosphate, and regional subunit distribution.

Authors:  T P Kasten; Y Mhaskar; G A Dunaway
Journal:  Mol Cell Biochem       Date:  1993-03-10       Impact factor: 3.396

8.  The subunit proportions and kinetic properties of 6-phosphofructo-1-kinase isozymes from rat heart atria and ventricle progressively change during aging.

Authors:  Y Mhaskar; G A Dunaway
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

9.  In-depth quantitative proteomic characterization of organotypic hippocampal slice culture reveals sex-specific differences in biochemical pathways.

Authors:  Simone Nardin Weis; Jaques Miranda F Souza; Juliana Bender Hoppe; Marina Firmino; Manfred Auer; Nassim N Ataii; Leonardo Assis da Silva; Mariana Maier Gaelzer; Caroline Peres Klein; Alan R Mól; Consuelo M R de Lima; Diogo Onofre Souza; Christianne G Salbego; Carlos André O Ricart; Wagner Fontes; Marcelo Valle de Sousa
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

10.  Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches.

Authors:  Peter M Fernandes; James Kinkead; Iain McNae; Paul A M Michels; Malcolm D Walkinshaw
Journal:  Biochem J       Date:  2020-11-27       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.